Crizotinib Capsules
Crizotinib Capsules
Anticancer Medicine / Targeted Therapy

Crizotinib Capsules

Crizotinib Capsules Manufacturer – Leading WHO-GMP certified manufacturer and global exporter of Crizotinib Capsules (Crizokast). High-quality, reliable, affordable medicine.

Formulation Capsules
Standard WHO-GMP Certified Quality
Supply Type Global Export & Institutional Supply
Finished Commercial Brand

Available finished formulation under our brand name Crizokast 250mg.

View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured

Formulation Insights

Comprehensive Medical Overview

Crizotinib Capsules

Classification: Anticancer Medicine / Targeted Therapy

About Crizotinib Capsules

Crizotinib is a targeted kinase inhibitor medication used in the treatment of ALK-positive and ROS1-positive non-small cell lung cancer (NSCLC), inhibiting abnormal proteins that signal cancer cells to multiply.

Crizotinib Capsules (Crizokast) Manufactured by Aprazer Healthcare

Crizokast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.